Could friendly bacteria in a gel shield women from HIV?
Prevention
Recruiting now
This early-stage study tests a new vaginal gel called MucoCept-CVN in 12 healthy women. The gel contains a modified version of a natural vaginal bacterium that continuously produces a potent anti-HIV drug. The goal is to see if it is safe and can be cleared with antibiotics, pavi…
Phase: PHASE1 • Sponsor: Craig Cohen, MD, MPH • Aim: Prevention
Last updated May 11, 2026 20:50 UTC